NDRG1 regulates neutral lipid metabolism in breast cancer cells.
NDRG1 regulates neutral lipid metabolism in breast cancer cells.
复制标题
DOI:
10.1186/s13058-018-0980-4
复制
发表时间:
2018-06-14
期刊:
影响因子:
--
通讯作者:
Conklin DS
中科院分区:
文献类型:
--
作者:
Sevinsky CJ;Khan F;Kokabee L;Darehshouri A;Maddipati KR;Conklin DS
Altered lipid metabolism is an emerging hallmark of aggressive breast cancers. The N-myc downstream regulated gene (NDRG1) gene plays a critical role in peripheral nervous system myelination, as inactivating mutations cause severe demyelinating neuropathy. In breast cancer, elevated NDRG1 expression has been linked to clinical outcomes, but its functional role in breast cancer physiology has remained unclear. A meta-analysis of NDRG1 expression in multiple large publicly available genomic databases was conducted. Genome-wide expression correlation and Cox proportional hazards and Kaplan-Meier modeling of clinical outcomes associated with elevated expression were assessed. To study NDRG1 function, gene silencing and overexpression phenotypic studies were carried out in a panel of cell lines representing all major breast cancer molecular subtypes. Changes in cell proliferation, morphology, and neutral lipid accumulation due to altered NDRG1 expression were assessed by high throughput, quantitative microscopy. Comprehensive lipidomics mass spectrometry was applied to characterize global changes in lipid species due to NDRG1 silencing. Labeled fatty acids were used to monitor cellular fatty acid uptake and subcellular distribution under nutrient replete and starvation culture conditions. NDRG1 overexpression correlated with glycolytic and hypoxia-associated gene expression, and was associated with elevated rates of metastasis and patient mortality. Silencing NDRG1 reduced cell proliferation rates, causing lipid metabolism dysfunction including increased fatty acid incorporation into neutral lipids and lipid droplets. Conversely, NDRG1 expression minimized lipid droplet formation under nutrient replete and starvation conditions. Here we report that NDRG1 contributes to breast cancer aggressiveness by regulating the fate of lipids in cells that exhibit an altered lipid metabolic phenotype. In line with its role in promoting myelination and its association with altered metabolism in cancer, our findings show that NDRG1 is a critical regulator of lipid fate in breast cancer cells. The association between NDRG1 and poor prognosis in breast cancer suggests it should play a more prominent role in patient risk assessment. The function of NDRG1 in breast cancer lipid metabolism may represent a promising therapeutic approach in the future. The online version of this article (10.1186/s13058-018-0980-4) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
9.3
作者:
Hu Z;Fan C;Livasy C;He X;Oh DS;Ewend MG;Carey LA;Subramanian S;West R;Ikpatt F;Olopade OI;van de Rijn M;Perou CM
通讯作者:
Perou CM
DOI:
10.1016/j.bbalip.2013.03.011
发表时间:
2013-10
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
Baumann J;Sevinsky C;Conklin DS
通讯作者:
Conklin DS
DOI:
10.1074/jbc.m115.682203
发表时间:
2015-10-30
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Boeszoermenyi A;Nagy HM;Arthanari H;Pillip CJ;Lindermuth H;Luna RE;Wagner G;Zechner R;Zangger K;Oberer M
通讯作者:
Oberer M
影响因子:
3.7
作者:
Kachhap SK;Faith D;Qian DZ;Shabbeer S;Galloway NL;Pili R;Denmeade SR;DeMarzo AM;Carducci MA
通讯作者:
Carducci MA
DOI:
10.1073/pnas.1503683112
发表时间:
2015-09-15
影响因子:
11.1
作者:
Croessmann, Sarah;Wong, Hong Yuen;Park, Ben Ho
通讯作者:
Park, Ben Ho